Skip to main content

Table 4 Adjusted odds ratio for death and/or default outcomes among HIV-infected TB patients.

From: Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in Thailand

1. Those with cure, complete, death outcomes
Comparison groups versus non-reactive All patients Culture-confirmed TB
  n AOR 95% CI n AOR 95% CI
    L U    L U
HBsAg + 385 1.0 0.3 3.3 188 0.5 0.1 4.9
Anti-HCV + 504 1.1 0.6 1.9 253 1.4 0.6 3.6
HBsAg and anti-HCV + 374 2.1 0.6 7.6 185 4.8 0.5 42.9
2. Those with cure, complete, death, and default outcomes
Comparison groups versus non-reactive All patients Culture-confirmed TB
  n AOR 95% CI n AOR 95% CI
    L U    L U
HBsAg + 420 2.7 1.1 6.4 207 5.5 1.4 21.9
Anti-HCV + 549 1.2 0.8 2.0 281 2.0 1.0 4.0
HBsAg and anti-HCV + 401 1.4 0.4 4.7 198 1.7 0.3 11.2
  1. + sign indicates reactive; bold type indicates statistical significance (p < 0.05); TB, tuberculosis, HIV, human immunodeficiency virus; AOR, adjusted odds ratio; CI, confidence interval; L, lower bound; U, upper bound; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus, N, number of patients included in the model.
  2. *Adjusted odds ratios from multivariate logistic regression analyses adjusted for TB disease severity, HIV disease severity, co-trimoxazole use, fluconazole use, anti-retroviral use, whether or not received directly observed therapy, hospitalized at enrollment and been treated for TB previously